These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33545284)

  • 1. Formulation of stabilizer-free, nontoxic PLGA and elastin-PLGA nanoparticle delivery systems.
    Stromberg ZR; Lisa Phipps M; Magurudeniya HD; Pedersen CA; Rajale T; Sheehan CJ; Courtney SJ; Bradfute SB; Hraber P; Rush MN; Kubicek-Sutherland JZ; Martinez JS
    Int J Pharm; 2021 Mar; 597():120340. PubMed ID: 33545284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.
    Prabha S; Labhasetwar V
    Pharm Res; 2004 Feb; 21(2):354-64. PubMed ID: 15032319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
    Rafiei P; Haddadi A
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
    Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
    Int J Pharm; 1999 Oct; 187(2):143-52. PubMed ID: 10502620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and biodegradable properties of hydroxyapatite nanoparticle composite coated with poly lactic-co-glycolic acid/polyvinyl alcohol for bone regeneration.
    Istikharoh F; Sujuti H; Mustamsir E; Swastirani A
    Dent Med Probl; 2020; 57(4):363-367. PubMed ID: 33448162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
    Sahoo SK; Panyam J; Prabha S; Labhasetwar V
    J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN; Bakowsky U; Lehr CM
    Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
    Alkholief M; Kalam MA; Anwer MK; Alshamsan A
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium.
    Samati Y; Yüksel N; Tarimci N
    Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
    Vandervoort J; Ludwig A
    Int J Pharm; 2002 May; 238(1-2):77-92. PubMed ID: 11996812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles.
    Grune C; Thamm J; Werz O; Fischer D
    J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles.
    Gossmann R; Langer K; Mulac D
    PLoS One; 2015; 10(7):e0127532. PubMed ID: 26147338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic protection and biocompatibility screening of enzyme-loaded polymeric nanoparticles for neurotherapeutic applications.
    Liao R; Pon J; Chungyoun M; Nance E
    Biomaterials; 2020 Oct; 257():120238. PubMed ID: 32738657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIOPHARMACEUTICAL UNDERSTANDING OF FORMULATION PREPARATION VARIABILITY OF PLGA NANOPARTICLES LOADED WITH ERYSIMUM EXTRACT.
    Ebralidze L; Tsertsvadze A; Bakuridze L; Berashvili D; Bakuridze A
    Georgian Med News; 2021 Feb; (311):173-177. PubMed ID: 33814414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-cancer activity of PLGA nanoparticles containing crocetin.
    Hafezi Ghahestani Z; Alebooye Langroodi F; Mokhtarzadeh A; Ramezani M; Hashemi M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):955-960. PubMed ID: 27327450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
    Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
    Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.